<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>PENDING</status><version>v2</version><patient-age>50</patient-age><report-id>PHHY2013JP002233</report-id><gender>female</gender><reactions><reaction>Non-HIV-related PML</reaction><reaction>JCV level (1.26 x 10E4 copies/ml)</reaction><reaction>Left facial numbness</reaction><reaction>Muscular weakness of the left arm</reaction><reaction>Creatinine level transiently increased</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>NEORAL</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>CELLCEPT</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>SIMULECT</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>PREDNISOLONE</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>PLASMAPHERESIS</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>IMMUNOGLOBULINS</drug-name><manufacturer/><ingredients/></drug></drugs><indications><indication>Renal transplant</indication><indication>Transplant rejection</indication></indications><patient-age>50</patient-age><outcomes><outcome>Life Threatening</outcome></outcomes><country>Japan</country><geo/></meta><original><ichicsr lang="en" xmlns="">
	<ichicsrmessageheader>
		<messagetype>ichicsr</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>2.0</messageformatrelease>
		<messagenumb>4149682_286</messagenumb>
		<messagesenderidentifier>NovartisPH</messagesenderidentifier>
		<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20130125152626</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>2</safetyreportversion>
		<safetyreportid>PHHY2013JP002233</safetyreportid>
		<primarysourcecountry>JP</primarysourcecountry>
		<occurcountry>JP</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>2013-01-25</transmissiondate>
		<reporttype>1</reporttype>
		<serious code="1">Yes</serious>
		<seriousnessdeath>2</seriousnessdeath>
		<seriousnesslifethreatening>1</seriousnesslifethreatening>
		<seriousnesshospitalization>2</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>1</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>2013-01-07</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>2013-01-21</receiptdate>
		<additionaldocument>2</additionaldocument>
		<fulfillexpeditecriteria>1</fulfillexpeditecriteria>
		<companynumb>PHHY2013JP002233</companynumb>
		<medicallyconfirm>1</medicallyconfirm>
		<primarysource>
			<reportergivename>Tatsuo</reportergivename>
			<reporterfamilyname>Yoneda</reporterfamilyname>
			<reporterorganization>Nara medical University</reporterorganization>
			<reporterstate>Nara Prefecture</reporterstate>
			<reportercountry>JP</reportercountry>
			<qualification code="1">Physician</qualification>
			<literaturereference>Ohara K et al. A Case of Promyelocytic Leukemia Developing during Immunosuppressor Therapy after Kidney Transplant. 97th Kinki Regional Meeting of Japanese Society of Neurology. 2012;28</literaturereference>
		</primarysource>
		<primarysource>
			<reportergivename>Keiye</reportergivename>
			<reporterfamilyname>Ohara</reporterfamilyname>
			<reporterorganization>Nara Medical University Hospital</reporterorganization>
			<reporterstate>Nara Prefecture</reporterstate>
			<reportercountry>JP</reportercountry>
			<qualification code="3">Other Health Professional</qualification>
		</primarysource>
		<sender>
			<sendertype>1</sendertype>
			<senderorganization>NOVARTIS PHARMACEUTICAL CORPORATION</senderorganization>
			<senderdepartment>Clinical Safety and Epidemiology</senderdepartment>
			<senderfamilyname>Clinical Safety and Epidemiology</senderfamilyname>
			<senderstreetaddress>Novartis Pharmaceuticals Corp. Bldg 419, One Health Plaza</senderstreetaddress>
			<sendercity>East Hanover</sendercity>
			<senderstate>NJ</senderstate>
			<senderpostcode>07936</senderpostcode>
			<sendercountrycode>US</sendercountrycode>
			<sendertel>+1800378</sendertel>
			<sendertelextension>8567</sendertelextension>
			<sendertelcountrycode>US</sendertelcountrycode>
			<senderfax>+1973781</senderfax>
			<senderfaxextension>8001</senderfaxextension>
			<senderfaxcountrycode>US</senderfaxcountrycode>
			<senderemailaddress>gdss.configuration@pharma.novartis.com</senderemailaddress>
		</sender>
		<receiver>
			<receivertype>2</receivertype>
			<receiverorganization>ZZFDA</receiverorganization>
			<receiverdepartment>FDA</receiverdepartment>
			<receivertitle>Mr</receivertitle>
			<receivergivename>William</receivergivename>
			<receiverfamilyname>Taylor</receiverfamilyname>
			<receiverstreetaddress>5600 Fishers Lane Room 16B-45</receiverstreetaddress>
			<receivercity>Rockville</receivercity>
			<receiverstate>MD</receiverstate>
			<receiverpostcode>20857</receiverpostcode>
			<receivercountrycode>US</receivercountrycode>
			<receivertel>+1301827</receivertel>
			<receivertelextension>0964</receivertelextension>
			<receivertelcountrycode>US</receivertelcountrycode>
			<receiverfax>+1301594</receiverfax>
			<receiverfaxextension>0829</receiverfaxextension>
			<receiverfaxcountrycode>US</receiverfaxcountrycode>
			<receiveremailaddress>.</receiveremailaddress>
		</receiver>
		<patient>
			<patientinitial>--</patientinitial>
			<patientonsetage>50</patientonsetage>
			<patientonsetageunit>801</patientonsetageunit>
			<patientsex code="2">Female</patientsex>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Glomerulonephritis chronic</patientepisodename>
				<patientmedicalstartdateformat>610</patientmedicalstartdateformat>
				<patientmedicalstartdate>198310</patientmedicalstartdate>
				<patientmedicalcontinue>3</patientmedicalcontinue>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Renal failure chronic</patientepisodename>
				<patientmedicalstartdateformat>610</patientmedicalstartdateformat>
				<patientmedicalstartdate>198902</patientmedicalstartdate>
				<patientmedicalcontinue>3</patientmedicalcontinue>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Renal transplant</patientepisodename>
				<patientmedicalstartdateformat>610</patientmedicalstartdateformat>
				<patientmedicalstartdate>198402</patientmedicalstartdate>
				<patientmedicalcontinue>3</patientmedicalcontinue>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Chronic allograft nephropathy</patientepisodename>
				<patientmedicalstartdateformat>610</patientmedicalstartdateformat>
				<patientmedicalstartdate>198706</patientmedicalstartdate>
				<patientmedicalcontinue>3</patientmedicalcontinue>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Transplant rejection</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Renal transplant</patientepisodename>
				<patientmedicalstartdateformat>102</patientmedicalstartdateformat>
				<patientmedicalstartdate>20070523</patientmedicalstartdate>
				<patientmedicalcontinue>3</patientmedicalcontinue>
			</medicalhistoryepisode>
			<reaction>
				<primarysourcereaction>Non-HIV-related PML</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Progressive multifocal leukoencephalopathy</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Progressive multifocal leukoencephalopathy</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionoutcome code="2">recovering/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>JCV level (1.26 x 10E4 copies/ml)</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>JC virus infection</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>JC virus infection</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>610</reactionstartdateformat>
				<reactionstartdate>201202</reactionstartdate>
				<reactionoutcome code="2">recovering/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Left facial numbness</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Numbness in face</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Hypoaesthesia</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>610</reactionstartdateformat>
				<reactionstartdate>201202</reactionstartdate>
				<reactionoutcome code="2">recovering/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Muscular weakness of the left arm</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Muscle weakness upper limb</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Muscular weakness</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>610</reactionstartdateformat>
				<reactionstartdate>201202</reactionstartdate>
				<reactionoutcome code="2">recovering/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Creatinine level transiently increased</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Creatinine increased</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Blood creatinine increased</reactionmeddrapt>
				<reactionoutcome code="1">recovered/resolved</reactionoutcome>
			</reaction>
			<test>
				<testname>Nuclear magnetic resonance imaging brain</testname>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testname>Polymerase chain reaction</testname>
				<moreinformation>2</moreinformation>
			</test>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>NEORAL</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugauthorizationcountry>JP</drugauthorizationcountry>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Renal transplant</drugindication>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>CICLOSPORIN</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Blood creatinine increased</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Blood creatinine increased</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Hypoaesthesia</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Hypoaesthesia</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>JC virus infection</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>JC virus infection</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Muscular weakness</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Muscular weakness</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Progressive multifocal leukoencephalopathy</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Progressive multifocal leukoencephalopathy</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>NEORAL</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugauthorizationcountry>JP</drugauthorizationcountry>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>CICLOSPORIN</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Blood creatinine increased</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Blood creatinine increased</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Hypoaesthesia</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Hypoaesthesia</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>JC virus infection</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>JC virus infection</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Muscular weakness</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Muscular weakness</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Progressive multifocal leukoencephalopathy</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Progressive multifocal leukoencephalopathy</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>CELLCEPT</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugauthorizationcountry>JP</drugauthorizationcountry>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Renal transplant</drugindication>
				<actiondrug code="1">Drug Withdrawn</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>MYCOPHENOLATE MOFETIL</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>SIMULECT</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugauthorizationcountry>JP</drugauthorizationcountry>
				<drugstructuredosagenumb>20</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugdosagetext>20 mg, UNK</drugdosagetext>
				<drugadministrationroute code="042">Intravenous (not otherwise specified)</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Renal transplant</drugindication>
				<actiondrug code="5">Unknown</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>BASILIXIMAB</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>PREDNISOLONE</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugauthorizationcountry>JP</drugauthorizationcountry>
				<drugstructuredosagenumb>5</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugdosagetext>5 mg, UNK</drugdosagetext>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Renal transplant</drugindication>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>PREDNISOLONE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>PLASMAPHERESIS</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugauthorizationcountry>JP</drugauthorizationcountry>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Transplant rejection</drugindication>
				<actiondrug code="5">Unknown</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>NO INGREDIENTS/SUBSTANCES</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>IMMUNOGLOBULINS</medicinalproduct>
				<obtaindrugcountry>JP</obtaindrugcountry>
				<drugauthorizationcountry>JP</drugauthorizationcountry>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Transplant rejection</drugindication>
				<actiondrug code="5">Unknown</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>NO INGREDIENTS/SUBSTANCES</activesubstancename>
				</activesubstance>
			</drug>
			<summary>
				<narrativeincludeclinical>Case number PHHY2013JP002233 is an <Semaphore x="1938518" class="Disease or Finding" value="First-Degree Burn" score="1.00" ID="C76130">initial </Semaphore>literature report received on 07 Jan 2013 and follow up report received from <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>on 21 Jan 2013. This report refers to a 50-year old female patient who had <Semaphore x="1779057" class="Disease or Finding" value="Chronic Glomerulonephritis" score="1.00" ID="C35173">chronic glomerulonephritis </Semaphore>and was undergoing <Semaphore x="2014361" class="Procedure" value="Hemodialysis" score="1.00" ID="C15248">hemodialysis </Semaphore>in Oct 1983. In Feb 1984 she underwent <Semaphore x="3228018" class="MedDRA LLT" value="Renal transplant" score="1.00" ID="10038533">renal <Semaphore x="1992543" class="AnatomicStructure" value="Graft" score="1.00" ID="C12981">transplant </Semaphore>for <Semaphore x="1781618" class="Disease or Finding" value="Chronic Renal Failure" score="1.00" ID="C9438">chronic renal </Semaphore></Semaphore>
    <Semaphore x="3226947" class="MedDRA LLT" value="Renal failure chronic" score="1.00" ID="10038444">
     <Semaphore x="1781618" class="Disease or Finding" value="Chronic Renal Failure" score="1.00" ID="C9438">failure </Semaphore></Semaphore>from her father. In Jun 1987, she developed <Semaphore x="1778504" class="Disease or Finding" value="Chronic Allograft Nephropathy" score="1.00" ID="C38145">chronic allograft nephropathy </Semaphore>and hence <Semaphore x="2014361" class="Procedure" value="Hemodialysis" score="1.00" ID="C15248">hemodialysis </Semaphore>was introduced again. In Feb 1989, <Semaphore x="1907579" class="Procedure" value="Excision" score="1.00" ID="C15232">extirpation </Semaphore>of <Semaphore x="3228018" class="MedDRA LLT" value="Renal transplant" score="1.00" ID="10038533">renal <Semaphore x="1992543" class="AnatomicStructure" value="Graft" score="1.00" ID="C12981">transplant </Semaphore></Semaphore>done. On 23 May 2007, she underwent again cadaveric <Semaphore x="3228018" class="MedDRA LLT" value="Renal transplant" score="1.00" ID="10038533">renal <Semaphore x="1992543" class="AnatomicStructure" value="Graft" score="1.00" ID="C12981">transplant</Semaphore></Semaphore>. She was started on <Semaphore x="913401" class="Medicine" value="Neoral" score="0.93" ID="241343">Neoral </Semaphore>(ciclosporin), <Semaphore x="1184784" class="Medicine" value="Simulect" score="0.74" ID="248914">Simulect </Semaphore>(<Semaphore x="187366" class="Medicine" value="basiliximab" score="0.49" ID="240085">Basiliximab</Semaphore>), Co suspect <Semaphore x="317973" class="Medicine" value="Cellcept" score="0.93" ID="239619">Cellcept </Semaphore>and <Semaphore x="1081705" class="Medicine" value="prednisoLONE" score="0.74" ID="291320">prednisolone</Semaphore>. After an unknown duration, she developed <Semaphore x="3286122" class="MedDRA LLT" value="Transplant rejection" score="1.00" ID="10044439">antibodymediated rejection </Semaphore>which was treated with <Semaphore x="2405985" class="Procedure" value="Plasmapheresis" score="1.00" ID="C15304">plasmapheresis </Semaphore>and IV <Semaphore x="1985970" class="Procedure" value="Globulin Protein Measurement" score="1.00" ID="C74738">globulins</Semaphore>. Fifteen day later <Semaphore x="2014361" class="Procedure" value="Hemodialysis" score="1.00" ID="C15248">hemodialysis </Semaphore>was <Semaphore x="2588752" class="Procedure" value="Study of High Risk Factors" score="1.00" ID="C62697">withdrawn</Semaphore>. In Feb 2012, the patient was aware that the <Semaphore x="1918283" class="AnatomicStructure" value="Face" score="1.00" ID="C13071">face </Semaphore>transiently felt numb on the left side and <Semaphore x="3117681" class="MedDRA LLT" value="Muscular weakness" score="1.00" ID="10028372"><Semaphore x="2247517" class="AnatomicStructure" value="Muscle" score="1.00" ID="C13056">muscular </Semaphore><Semaphore x="2697667" class="Disease or Finding" value="Weakness" score="1.00" ID="C50809">weakness </Semaphore>of the <Semaphore x="2101093" class="AnatomicStructure" value="Left Arm" score="1.00" ID="C105633">left arm </Semaphore></Semaphore>(patient had difficulty gripping things). And thus, the patient visited a local clinic. <Semaphore x="2149241" class="Procedure" value="Magnetic Resonance Imaging" score="1.00" ID="C16809">Magnetic resonance imaging </Semaphore>(<Semaphore x="2149241" class="Procedure" value="Magnetic Resonance Imaging" score="1.00" ID="C16809">MRI</Semaphore>) revealed high <Semaphore x="2520982" class="Disease or Finding" value="Signal Transduction Alteration" score="1.00" ID="C41534">signal </Semaphore>intensity area under the right sided parietal <Semaphore x="1947844" class="Disease or Finding" value="Frontal Lobe Neoplasm" score="1.00" ID="C5572">cortex, right frontal </Semaphore>operculum and right <Semaphore x="1527958" class="AnatomicStructure" value="Angular Gyrus" score="1.00" ID="C32077">angular gyrus </Semaphore>on T2 <Semaphore x="3320545" class="MedDRA LLT" value="Weight" score="1.00" ID="10047890">weighted </Semaphore><Semaphore x="2044649" class="Procedure" value="Imaging Technique" score="1.00" ID="C17369">image</Semaphore>, <Semaphore x="2592399" class="Race" value="Sugpiaq" score="1.00" ID="C44488">suggesting </Semaphore><Semaphore x="2425401" class="Disease or Finding" value="Progressive Multifocal Leukoencephalopathy" score="1.00" ID="C26815">Progressive multifocal leukoencephalopathy </Semaphore>(<Semaphore x="2425401" class="Disease or Finding" value="Progressive Multifocal Leukoencephalopathy" score="1.00" ID="C26815">PML</Semaphore>). The patient was transferred to the reporting <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician</Semaphore>’s hospital. Despite <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore>with Aciclovir (aciclovir) which was initiated at previous clinic, worsening was found on <Semaphore x="2044649" class="Procedure" value="Imaging Technique" score="1.00" ID="C17369">image</Semaphore>; <Semaphore x="317973" class="Medicine" value="Cellcept" score="0.93" ID="239619">Cellcept </Semaphore>was stopped. <Semaphore x="2412052" class="Procedure" value="Polymerase Chain Reaction" score="1.00" ID="C17003">Polymerase chain reaction </Semaphore>(<Semaphore x="1803898" class="Disease or Finding" value="Complete Remission" score="1.00" ID="C4870">PCR</Semaphore>) with the spinal fluid showed <Semaphore x="3009038" class="MedDRA LLT" value="HIV test negative" score="1.00" ID="10020187">HIV <Semaphore x="2265745" class="Disease or Finding" value="Negative Patch Test" score="1.00" ID="C35633">negative </Semaphore></Semaphore>but had high <Semaphore x="1747820" class="AnatomicStructure" value="Cerebrospinal Fluid" score="1.00" ID="C12692">cerebrospinal fluid </Semaphore>JCV <Semaphore x="779631" class="Medicine" value="Level" score="0.87" ID="187620">level </Semaphore>(1.26 x 10E4 copies/ml). A <Semaphore x="1846062" class="Procedure" value="Diagnosis" score="1.00" ID="C15220">diagnosis </Semaphore>of non HIV related <Semaphore x="2425401" class="Disease or Finding" value="Progressive Multifocal Leukoencephalopathy" score="1.00" ID="C26815">PML </Semaphore>was <Semaphore x="2199623" class="Occupation" value="Manufacturer" score="1.00" ID="C25392">made</Semaphore>. <Semaphore x="913401" class="Medicine" value="Neoral" score="0.93" ID="241343">Neoral </Semaphore>was stopped. The dose of <Semaphore x="1081705" class="Medicine" value="prednisoLONE" score="0.74" ID="291320">prednisolone </Semaphore>was reduced to 5mg. Since that, although the <Semaphore x="2050560" class="Disease or Finding" value="Increased Creatinine" score="1.00" ID="C78249">creatinine <Semaphore x="779631" class="Medicine" value="Level" score="0.87" ID="187620">level </Semaphore>transiently increased</Semaphore>, the function of the <Semaphore x="3228018" class="MedDRA LLT" value="Renal transplant" score="1.00" ID="10038533">renal <Semaphore x="1992543" class="AnatomicStructure" value="Graft" score="1.00" ID="C12981">transplant </Semaphore></Semaphore>had been stable, and the <Semaphore x="2107425" class="Disease or Finding" value="Lesion" score="1.00" ID="C3824">lesion </Semaphore>of the <Semaphore x="2008843" class="AnatomicStructure" value="Head" score="1.00" ID="C12419">head </Semaphore>had diminished on <Semaphore x="2044649" class="Procedure" value="Imaging Technique" score="1.00" ID="C17369">image</Semaphore>. Therefore, on 72nd day of the disease, the patient was discharged from hospital. As of the time of this report, the patient was followed up on an outpatient <Semaphore x="187403" class="Medicine" value="Basis" score="0.49" ID="189629">basis</Semaphore>, receiving Mizoribine (mizoribine) and <Semaphore x="913401" class="Medicine" value="Neoral" score="0.93" ID="241343">Neoral</Semaphore>. Events were considered as serious and life threatening by reporting <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician</Semaphore>. The <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>commented that "<Semaphore x="317973" class="Medicine" value="Cellcept" score="0.93" ID="239619">Cellcept </Semaphore>(<Semaphore x="894462" class="Medicine" value="mycophenolate mofetil" score="0.49" ID="279461">mycophenolate mofetil</Semaphore>) was a causal factor of Non HIV related <Semaphore x="2425401" class="Disease or Finding" value="Progressive Multifocal Leukoencephalopathy" score="1.00" ID="C26815">PML </Semaphore>and causal relationship between this event and <Semaphore x="913401" class="Medicine" value="Neoral" score="0.93" ID="241343">Neoral </Semaphore>was uncertain"Follow up literature report received on 21 Jan 2013: Updated medical history, suspect brand name, new co medication (<Semaphore x="1081881" class="Medicine" value="predniSONE" score="0.49" ID="291353">prednisone</Semaphore>, <Semaphore x="1184784" class="Medicine" value="Simulect" score="0.74" ID="248914">Simulect</Semaphore>) Changed concomitant to suspect product (<Semaphore x="317973" class="Medicine" value="Cellcept" score="0.93" ID="239619">CellCept</Semaphore>), Event onset date and <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome</Semaphore>, action taken with suspect product, <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore>given<Semaphore x="2246005" class="AnatomicStructure" value="Muscle and Fasciae of the Thorax" score="1.00" ID="C33145">, new events (<Semaphore x="3117681" class="MedDRA LLT" value="Muscular weakness" score="1.00" ID="10028372">muscular <Semaphore x="2697667" class="Disease or Finding" value="Weakness" score="1.00" ID="C50809">weakness</Semaphore></Semaphore>, </Semaphore><Semaphore x="2326314" class="Disease or Finding" value="Numbness" score="1.00" ID="C34857">numbness</Semaphore>, <Semaphore x="2050560" class="Disease or Finding" value="Increased Creatinine" score="1.00" ID="C78249">creatinine <Semaphore x="779631" class="Medicine" value="Level" score="0.87" ID="187620">level </Semaphore>transiently increased</Semaphore>), <Semaphore x="2091429" class="Disease or Finding" value="Laboratory Test Result" score="1.00" ID="C36292">lab </Semaphore>data and author comment.</narrativeincludeclinical>
				<sendercomment>MAC: The event progressive JC virus infection is consistent with immunosuppressant drugs known pharmacology; hence a causal relationship to drug cannot be excluded. Hypoaesthesia  and muscular weakness can be symptoms of neurological manifestation of JC virus infection.</sendercomment>
			</summary>
		</patient>
	</safetyreport>
</ichicsr></original></faers>